Breaking News Instant updates and real-time market news.

2020-02-26 16:01:32 QGEN Qiagen $35.13 / +0.14 (+0.40%) 16:01 02/26/20 02/26 16:01 02/26/20 16:01	Qiagen announces shipments of test kits for coronavirus SARS-CoV-2 QIAGEN announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 and adds rapid Sample to Insight syndromic testing to QIAGEN's portfolio of molecular testing solutions in the public health emergency. QIAGEN is also in the process of shipping QIAstat-Dx testing kits to public health institutions in other regions, including Europe, South-East Asia, and the Middle East. Since January QIAGEN has been providing instruments and consumables to support detection of the virus in China and other markets. Official protocols for SARS-CoV-2 detection include QIAGEN extraction kits, reagents and instruments for real-time polymerase chain reaction workflows. Customers also are deploying QIAsymphony modular instruments and NeuMoDx integrated PCR systems to automate higher-throughput processing of their laboratory-developed tests for SARS-CoV-2.
QGEN Qiagen $35.13 / +0.14 (+0.40%) 02/05/20 Piper Sandler Qiagen price target raised to $36 from $29 at Piper Sandler 01/07/20 Wells Fargo Qiagen initiated with an Equal Weight at Wells Fargo 01/06/20 Citi Qiagen initiated with a Neutral at Citi 01/06/20 Commerzbank Qiagen downgraded to Hold from Buy at Commerzbank

2020-02-26 16:01:32

QGEN

Qiagen

$35.13 / +0.14 (+0.40%)

16:01

02/26/20

02/26

16:01

02/26/20

16:01

Qiagen announces shipments of test kits for coronavirus SARS-CoV-2

QIAGEN announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 and adds rapid Sample to Insight syndromic testing to QIAGEN's portfolio of molecular testing solutions in the public health emergency. QIAGEN is also in the process of shipping QIAstat-Dx testing kits to public health institutions in other regions, including Europe, South-East Asia, and the Middle East. Since January QIAGEN has been providing instruments and consumables to support detection of the virus in China and other markets. Official protocols for SARS-CoV-2 detection include QIAGEN extraction kits, reagents and instruments for real-time polymerase chain reaction workflows. Customers also are deploying QIAsymphony modular instruments and NeuMoDx integrated PCR systems to automate higher-throughput processing of their laboratory-developed tests for SARS-CoV-2.

QGEN Qiagen

$35.13 / +0.14 (+0.40%)

02/05/20 Piper Sandler: Qiagen price target raised to $36 from $29 at Piper Sandler

01/07/20 Wells Fargo: Qiagen initiated with an Equal Weight at Wells Fargo

01/06/20 Citi: Qiagen initiated with a Neutral at Citi

01/06/20 Commerzbank: Qiagen downgraded to Hold from Buy at Commerzbank

TODAY'S FREE FLY STORIES

Recommendations	JPMorgan lowers Bloom Energy target but not prefers over Nikola » 07:31 03/05/21 03/05 07:31 03/05/21 07:31 BE Bloom Energy $26.61 / -0.02 (-0.08%) , NKLA Nikola $16.04 / -0.49 (-2.96%) JPMorgan analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 12/09/20 Bloom Energy falls -15.3% 11/18/20 Bloom Energy, SK E&C announce they won RFP to supply SOFC in Korea 09/18/20 Bloom Energy rises 18.1% 09/18/20 Bloom Energy rises 10.7% NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola sees delivering first Nikola Tre BEVs to customers during Q4 02/25/21 Nikola CEO says 'necessary changes' made in Q4 to 'refocus and realign' company 02/23/21 Nikola provides update on North American hydrogen fuel-cell vehicle program 01/14/21 Worthington sells it remaining 7.05M shares of Nikola BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 03/04/21 Raymond James Bloom Energy upgraded to Outperform from Market Perform at Raymond James 03/04/21 Raymond James Bloom Energy upgraded to Outperform from Market Perform at Raymond James 02/03/21 Bernstein Bloom Energy initiated with a Market Perform at Bernstein 01/20/21 Credit Suisse Bloom Energy downgraded to Neutral from Outperform at Credit Suisse NKLA Nikola $16.04 / -0.49 (-2.96%) 04:56 Today JPMorgan Nikola downgraded to Neutral from Overweight at JPMorgan 02/01/21 Fly Intel: Top five analyst upgrades 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 12/28/20 JPMorgan JPMorgan cuts Nikola target but sees 'generally positive' news flow in 2021 BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 02/10/21 Bloom Energy sees FY21 revenue $950M-$1.0B, consensus $978.24M 02/10/21 Bloom Energy reports Q4 EPS (8c), consensus 0c 10/29/20 Bloom Energy reports Q3 net loss $12.0M NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola reports Q4 adjusted EPS (17c), consensus (23c) 02/25/21 Notable companies reporting after market close 11/09/20 Nikola reports Q3 adjusted EPS (16c), consensus (19c) 11/09/20 Notable companies reporting after market close 15 Oct 02 Oct BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 12/08/20 Rapidly changing industry foiled Bloom Energy's vision, WSJ says 10/14/20 Bloom Energy holder Canada Pension Plan exiting stake, Bloomberg says NKLA Nikola $16.04 / -0.49 (-2.96%) 02/26/21 Nikola's review finds several of Milton's claims 'inaccurate,' FT reports 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 02/12/21 Nikola, APS electricity deal approved by state regulators, AZ Big Media says BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 10/29/20 Fly Intel: After-Hours Movers 10/12/20 Fly Insider: Element Solutions, Sunrun among week's notable insider trades NKLA Nikola $16.04 / -0.49 (-2.96%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 03/19/21 Electric Truck Day BE NKLA BE Bloom Energy $26.61 / -0.02 (-0.08%) 12/08/20 Bloom Energy call volume above normal and directionally bullish 12/04/20 Bloom Energy call volume above normal and directionally bullish 11/24/20 Bloom Energy call volume above normal and directionally bullish 11/23/20 Bloom Energy call volume above normal and directionally bullish NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola options imply 19.4% move in share price post-earnings 02/03/21 Nikola call volume above normal and directionally bullish 01/27/21 Nikola call volume above normal and directionally bullish 01/26/21 Nikola call volume above normal and directionally bullish
Hot Stocks	Wipro to acquire Capco in $1.45B transaction 07:30 03/05/21 03/05 07:30 03/05/21 07:30 WIT Wipro $6.44 / -0.02 (-0.31%) ShowHide Related Items >><< Company News Street Research Earnings WIT Wipro $6.44 / -0.02 (-0.31%) 03/04/21 Wipro to acquire Capco 02/15/21 Wipro announces five-year strategic partnership with Telefonica Germany 01/15/21 Wipro chosen by Fiat Chrysler to establish first global digital hub in India 01/13/21 Wipro sees Q4 IT Services revenue up 1.5%-3.5% sequentially to $2.1B-$2.14B WIT Wipro $6.44 / -0.02 (-0.31%) 05:22 Today ICICI Securities Wipro downgraded to Sell from Reduce at ICICI Securities 12/21/20 Goldman Sachs Wipro resumed with a Sell at Goldman Sachs 10/14/20 Investec Wipro downgraded to Hold from Buy at Investec 10/06/20 ICICI Securities Wipro downgraded to Hold from Buy at ICICI Securities WIT Wipro $6.44 / -0.02 (-0.31%) 01/13/21 Wipro reports Q3 EPS 7c, two estimates 6c 10/13/20 Wipro sees Q3 IT Services revenue up 1.5%-3.5% sequentially to $2.02B-$2.06B 10/13/20 Wipro reports Q2 EPS 6c, two estimates 6c
Recommendations	Jacobs Engineering price target raised to $130 from $120 at Benchmark » 07:29 03/05/21 03/05 07:29 03/05/21 07:29 J Jacobs Engineering $112.85 / -2.215 (-1.92%) Benchmark analyst Josh… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings J Jacobs Engineering $112.85 / -2.215 (-1.92%) 03/04/21 Jacobs Engineering awarded $10.4M contract by DSRL for nuclear clean-up 02/25/21 Jacobs Engineering selected by NYCEDC for maritime consultant services 01/27/21 Jacobs raises quarterly dividend to 21c from 19c per share 01/26/21 Jacobs Engineering awarded contract by U.S. NAVFAC J Jacobs Engineering $112.85 / -2.215 (-1.92%) 01/15/21 Barclays Jacobs Engineering price target raised to $125 from $115 at Barclays 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/05/21 Baird Jacobs Engineering downgraded to Neutral from Outperform at Baird 11/30/20 UBS Jacobs Engineering price target raised to $122 from $104 at UBS J Jacobs Engineering $112.85 / -2.215 (-1.92%) 02/09/21 Jacobs Engineering raises FY21 adjusted EPS view to $5.30-$6.00 from $5.20-$6.00 02/09/21 Jacobs Engineering reports Q1 adjusted EPS $1.41, consensus $1.27 11/24/20 Jacobs Engineering sees FY21 adj. EPS $5.20-$6.00, consensus $5.81 11/24/20 Jacobs Engineering reports Q4 adj. EPS $1.63, consensus $1.32
Upgrade	JPMorgan upgrades Darling Ingredients on 'substantial upside potential' » 07:28 03/05/21 03/05 07:28 03/05/21 07:28 DAR Darling Ingredients $67.93 / +1.78 (+2.69%) JPMorgan analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DAR Darling Ingredients $67.93 / +1.78 (+2.69%) 01/28/21 Darling Ingredients, Valero joint venture receives approval for Texas facility 10/27/20 Darling Ingredients' joint venture receives air permit from TCEQ DAR Darling Ingredients $67.93 / +1.78 (+2.69%) 04:48 Today JPMorgan Darling Ingredients upgraded to Overweight from Neutral at JPMorgan 03/04/21 Credit Suisse Darling Ingredients price target raised to $95 from $80 at Credit Suisse 03/04/21 BMO Capital Darling Ingredients price target raised to $72 from $63 at BMO Capital 03/04/21 Baird Darling Ingredients price target raised to $75 from $71 at Baird DAR Darling Ingredients $67.93 / +1.78 (+2.69%) 03/02/21 Darling Ingredients reports Q4 adjusted EPS 45c, consensus 41c 11/03/20 Darling Ingredients reports Q3 GAAP EPS 61c, consensus 44c 03/15/21 33rd Annual Roth Virtual Conference 03/18/21 Waste & Environmental Services Virtual Symposium
Hot Stocks	Norwegian Cruise Line drops 8% to $30.34 after 47.58M ordinary share offering 07:28 03/05/21 03/05 07:28 03/05/21 07:28 NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 02/25/21 Norwegian Cruise Line sees Q1 CapEx approx. $90M 02/25/21 Norwegian Cruise Line: 2022 booking trends 'very positive' 02/25/21 Norwegian Cruise Line sees Q1 average cash burn reate remaining elevated 02/16/21 Norwegian Cruise Line extends suspension of voyages through May 31 NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 03/02/21 Fly Intel: Top five analyst upgrades 03/02/21 Macquarie Norwegian Cruise Line upgraded to Outperform from Neutral at Macquarie 02/26/21 Deutsche Bank Norwegian Cruise Line price target raised to $25 from $22 at Deutsche Bank 02/12/21 Berenberg Norwegian Cruise Line downgraded to Hold from Buy at Berenberg NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 02/25/21 Norwegian Cruise Line reports Q4 adjusted EPS ($2.33), consensus ($2.17) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 11/09/20 Norwegian Cruise Line reports Q3 adj. EPS ($2.35), consensus ($2.24) 18 Nov 17 Jul 06 May NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 02/05/21 Norwegian added to Hedgeye 'best idea short list,' Bloomberg reports 12/26/20 Caesars, Wynn among leisure stocks to play rebound, Barron's says 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/25/21 Fly Intel: Pre-market Movers 11/18/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Fly Intel: Pre-market Movers NCLH Norwegian Cruise Line $32.92 / -0.2 (-0.60%) 03/03/21 Early notable gainers among liquid option names on March 3rd 03/03/21 Unusually active option classes on open March 3rd 02/25/21 Unusually active option classes on open February 25th 02/24/21 Norwegian Cruise Line call volume above normal and directionally bullish

Recommendations	MasterCard price target raised to $450 from $415 at Truist » 07:26 03/05/21 03/05 07:26 03/05/21 07:26 MA MasterCard $349.02 / -11.03 (-3.06%) Truist analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MA MasterCard $349.02 / -11.03 (-3.06%) 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/10/21 MasterCard to start support select cryptocurrencies on its network 02/03/21 Veon, MasterCard announce strategic financial services partnership 01/28/21 MasterCard says 'driving hard' with customer engagement MA MasterCard $349.02 / -11.03 (-3.06%) 02/01/21 BofA US 1 List changes at BofA 01/27/21 KeyBanc MasterCard downgraded to Sector Weight at KeyBanc given reduced visibility 01/27/21 Bernstein MasterCard reinitiated with an Outperform at Bernstein 01/26/21 KeyBanc MasterCard downgraded to Sector Weight from Overweight at KeyBanc MA MasterCard $349.02 / -11.03 (-3.06%) 01/28/21 MasterCard reports Q4 EPS $1.64, consensus $1.51 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 01/25/21 Fly Intel: What to watch in credit card space earnings reports MA MasterCard $349.02 / -11.03 (-3.06%) 03/03/21 Durbin urges MasterCard, Visa to hold off on interchange fee hike, WLDS says 03/03/21 Durbin urges MasterCard, Visa not to hike interchange fees, WSJ reports 02/24/21 Visa, MasterCard plan to raise swipe fees in April, WSJ reports 12/27/20 MasterCard report says U.S. holiday retail sales up 3%, Reuters reports MA MasterCard $349.02 / -11.03 (-3.06%) 02/12/21 The Intersection: Crypto and Wall Street This Week 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 01/28/21 Fly Intel: Pre-market Movers MA MasterCard $349.02 / -11.03 (-3.06%) 02/23/21 Mastercard call volume above normal and directionally bullish 02/22/21 Mastercard call volume above normal and directionally bullish 02/11/21 Unusually active option classes on open February 11th 01/14/21 Mastercard call volume above normal and directionally bullish
Upgrade	JPMorgan upgrades Cisco on spending recovery, 'inexpensive' valuation » 07:26 03/05/21 03/05 07:26 03/05/21 07:26 CSCO Cisco / + JPMorgan analyst Samik… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CSCO Cisco / + 03/01/21 Cisco completes acquisition of Acacia Communications 02/16/21 Cisco says IMImobile offer approved by South African competition authorities 02/09/21 Cisco falls over 3% to $47 per share after Q2 earnings, Q3 guidance 02/09/21 Cisco increases quarterly dividend 3% to 37c per share CSCO Cisco / + 04:49 Today JPMorgan Cisco upgraded to Overweight from Neutral at JPMorgan 02/11/21 DZ Bank Cisco upgraded to Buy from Hold at DZ Bank 02/10/21 Evercore ISI Cisco trends 'slowly but steadily inflecting higher,' says Evercore ISI 02/10/21 Citi Cisco price target raised to $50 from $45 at Citi CSCO Cisco / + 02/09/21 Cisco sees Q3 adjusted EPS 80c-82c, consensus 81c 02/09/21 Cisco reports Q2 adjusted EPS 79c, consensus 76c 02/09/21 Notable companies reporting after market close 11/12/20 Cisco jumps 8% to $41.72 after Q1 results beat estimates CSCO Cisco / + 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/14/21 Cisco in new deal to acquire Acacia for $115 per share, CNBC reports 01/08/21 Cisco to get order to temporarily stop Acacia ending merger deal, Bloomberg says 01/08/21 Cisco sues Acacia to stop company from breaking merger pact, Bloomberg reports CSCO Cisco / + 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: After-Hours Movers 04/08/21 Network Security 05/19/21 Cisco - CSCO CSCO Cisco / + 02/08/21 Unusually active option classes on open February 8th 02/05/21 Unusually active option classes on open February 5th 02/04/21 Unusually active option classes on open February 4th 01/11/21 Cisco call volume above normal and directionally bullish
Recommendations	Broadcom price target raised to $538 from $521 at Morgan Stanley » 07:26 03/05/21 03/05 07:26 03/05/21 07:26 AVGO Broadcom $443.23 / -19.235 (-4.16%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom CFO says delivered about $3B in free cash flow in Q1 02/22/21 ForeScout appoints Kevin O'Leary chief product officer 12/21/20 Broadcom CEO sells over 14,000 common shares 12/16/20 Synnex awarded commercial aggregator agreement with Broadcom AVGO Broadcom $443.23 / -19.235 (-4.16%) 07:19 Today RBC Capital Broadcom price target raised to $460 from $450 at RBC Capital 06:59 Today Wells Fargo Broadcom price target raised to $450 from $410 at Wells Fargo 06:46 Today Deutsche Bank Broadcom price target raised to $500 from $475 at Deutsche Bank 06:38 Today Mizuho Broadcom price target raised to $490 from $480 at Mizuho AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom sees Q2 revenue approximately $6.5B, consensus $6.33B 03/04/21 Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55 03/04/21 Notable companies reporting after market close 12/10/20 Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Fly Intel: After-Hours Movers 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/11/20 Fly Intel: Wall Street's top stories for Friday 08:30 Today Broadcom - AVGO 04/05/21 Broadcom Inc. AVGO Broadcom $443.23 / -19.235 (-4.16%) 11/03/20 Unusually active option classes on open November 3rd
Conference/Events	Morgan Stanley Euro capital goods analysts hold analyst/industry conference call » 07:25 03/05/21 03/05 07:25 03/05/21 07:25 European Capital Goods… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Burlington Stores price target raised to $320 from $295 at RBC Capital » 07:24 03/05/21 03/05 07:24 03/05/21 07:24 BURL Burlington Stores $281.99 / +29.43 (+11.65%) RBC Capital analyst Kate… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options BURL Burlington Stores $281.99 / +29.43 (+11.65%) 03/04/21 Burlington Stores rises 13.7% 03/04/21 Burlington Stores rises 10.4% 03/04/21 Burlington Stores reports Q4 gross margin 42.5% vs. 42.1% last year 03/04/21 Burlington Stores sees FY21 CapEx $470M BURL Burlington Stores $281.99 / +29.43 (+11.65%) 06:48 Today Deutsche Bank Burlington Stores price target raised to $320 from $279 at Deutsche Bank 06:46 Today Baird Burlington Stores price target raised to $325 from $295 at Baird 02/16/21 JPMorgan Burlington Stores price target raised to $259 from $254 at JPMorgan 01/27/21 Citi Burlington Stores downgraded to Neutral from Buy at Citi BURL Burlington Stores $281.99 / +29.43 (+11.65%) 03/04/21 Burlington Stores reports Q4 adjusted EPS $2.44, consensus $2.12 03/03/21 Notable companies reporting before tomorrow's open 03/03/21 Notable companies reporting before tomorrow's open 11/24/20 Burlington Stores reports Q3 non-GAAP EPS 29c, consensus 16c BURL Burlington Stores $281.99 / +29.43 (+11.65%) 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 03/04/21 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: Pre-market Movers BURL Burlington Stores $281.99 / +29.43 (+11.65%) 10/09/20 Unusual call flow in option market yesterday 10/08/20 Call spread in Burlington Stores rolls two week 300% winner

Recommendations	Chuy's price target raised to $44 from $32 at Stephens » 07:23 03/05/21 03/05 07:23 03/05/21 07:23 CHUY Chuy's / + Stephens analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHUY Chuy's / + 03/04/21 Chuy's to open four to six new restaurants in FY21 CHUY Chuy's / + 02/25/21 BMO Capital Chuy's downgraded to Market Perform from Outperform at BMO Capital 02/10/21 Raymond James Chuy's downgraded to Market Perform at Raymond James on valuation 02/10/21 Raymond James Chuy's downgraded to Market Perform from Outperform at Raymond James 01/15/21 Stifel Chuy's upgraded to Buy from Hold at Stifel CHUY Chuy's / + 03/04/21 Chuy's reports Q4 EPS 19c, consensus 14c 11/05/20 Chuy's not providing FY20 guidance 11/05/20 Chuy's reports Q3 EPS 31c, consensus 12c
Recommendations	T2 Biosystems price target lowered to $1.65 from $2.40 at Alliance Global » 07:23 03/05/21 03/05 07:23 03/05/21 07:23 TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 07:13 Today Alliance Global Partners T2 Biosystems price target lowered to $1.65 from $2.40 at Alliance Global Partners 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems sees FY21 revenue $24M-$26M, consensus $33.27M 03/04/21 T2 Biosystems reports Q4 EPS (7c), consensus (7c) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems options imply 26.4% move in share price post-earnings 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names
Upgrade	HarborOne Bancorp upgraded to Buy from Neutral at DA Davidson » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) DA Davidson analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) 02/19/21 Piper Sandler HarborOne Bancorp downgraded to Neutral from Overweight at Piper Sandler 06/16/20 DA Davidson HarborOne Bancorp initiated with a Neutral at DA Davidson 06/15/20 DA Davidson HarborOne Bancorp initiated with a Neutral at DA Davidson HONE HarborOne Bancorp $12.77 / -0.145 (-1.12%) 01/28/21 HarborOne Bancorp reports Q4 EPS 33c, consensus 22c 10/27/20 HarborOne Bancorp reports Q3 EPS 22c, consensus 17c
General news	European stock markets are mostly lower » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	FX Update: The dollar has continued to ascend » 07:20 03/05/21 03/05 07:20 03/05/21 07:20 FX Update: The dollar has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Recommendations	Broadcom price target raised to $460 from $450 at RBC Capital » 07:19 03/05/21 03/05 07:19 03/05/21 07:19 AVGO Broadcom $443.23 / -19.235 (-4.16%) RBC Capital analyst Mitch… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom CFO says delivered about $3B in free cash flow in Q1 02/22/21 ForeScout appoints Kevin O'Leary chief product officer 12/21/20 Broadcom CEO sells over 14,000 common shares 12/16/20 Synnex awarded commercial aggregator agreement with Broadcom AVGO Broadcom $443.23 / -19.235 (-4.16%) 06:59 Today Wells Fargo Broadcom price target raised to $450 from $410 at Wells Fargo 06:46 Today Deutsche Bank Broadcom price target raised to $500 from $475 at Deutsche Bank 06:38 Today Mizuho Broadcom price target raised to $490 from $480 at Mizuho 06:31 Today KeyBanc Broadcom price target raised to $540 from $470 at KeyBanc AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Broadcom sees Q2 revenue approximately $6.5B, consensus $6.33B 03/04/21 Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55 03/04/21 Notable companies reporting after market close 12/10/20 Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B AVGO Broadcom $443.23 / -19.235 (-4.16%) 03/04/21 Fly Intel: After-Hours Movers 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/11/20 Fly Intel: Wall Street's top stories for Friday 08:30 Today Broadcom - AVGO 04/05/21 Broadcom Inc. AVGO Broadcom $443.23 / -19.235 (-4.16%) 11/03/20 Unusually active option classes on open November 3rd
Recommendations	Microsoft price target raised to $290 from $285 at Morgan Stanley » 07:19 03/05/21 03/05 07:19 03/05/21 07:19 MSFT Microsoft $226.81 / -0.81 (-0.36%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Verb Technology readies for release of Microsoft Outlook integration 03/04/21 Schlumberger, Chevron and Microsoft collaborate on carbon negative bioenergy 03/03/21 Microsoft debuts Group Transcribe, a new Garage app for transcriptions 03/02/21 Microsoft introduces Microsoft Mesh to connect with new depth and dimension MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/03/21 Citi Microsoft assumed with a Buy at Citi 02/16/21 Wedbush Microsoft price target raised to $300 from $285 at Wedbush 02/16/21 UBS Workday price target raised to $280 from $235 at UBS 02/08/21 KeyBanc Viva reinforces Microsoft Office/Teams innovation commitment, says KeyBanc MSFT Microsoft $226.81 / -0.81 (-0.36%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Microsoft president Smith to testify at 'Big Tech' antitrust hearing, Axios says 02/28/21 Microsoft says vaccine tools have 'fallen short,' Bloomberg reports 02/23/21 Google lobbying Senate to press Microsoft on SolarWinds hack, Politico reports 02/22/21 Google hit with class-action suit over Stadia 4K promises, PCGamer says MSFT Microsoft $226.81 / -0.81 (-0.36%) 03/04/21 Fly Intel: What to watch in Slack earnings report 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/24/21 Fly Intel: What to watch in Nvidia earnings report 03/10/21 2nd Annual Enterprise Comms Virtual Summit MSFT Microsoft $226.81 / -0.81 (-0.36%) 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th
Recommendations	Gap price target raised to $29 from $27 at Morgan Stanley » 07:16 03/05/21 03/05 07:16 03/05/21 07:16 GPS Gap $25.43 / -0.31 (-1.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Gap recorded $56M impairment charge in Q4 related to Intermix 03/04/21 Gap reports Q4 Old Navy Global SSS up 7% y/y 02/24/21 Gap to open distribution center in Longview, Texas 01/21/21 Gap's Athleta adds extended sizing to 350 styles in its 200 stores, online GPS Gap $25.43 / -0.31 (-1.20%) 06:48 Today Baird Gap price target raised to $29 from $25 at Baird 06:28 Today Citi Gap margins better than expected, at Citi 06:26 Today UBS Gap price target raised to $28 from $25 at UBS 02/16/21 Jefferies Gap assumed with a Hold at Jefferies GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y GPS Gap $25.43 / -0.31 (-1.20%) 06:07 Today Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/20/20 Gap reviewing options for its Gap Europe business, Bloomberg says GPS Gap $25.43 / -0.31 (-1.20%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday GPS Gap $25.43 / -0.31 (-1.20%) 02/02/21 Gap call volume above normal and directionally bullish 11/27/20 Notable open interest changes for November 27th 11/24/20 Gap options imply 9.2% move in share price post-earnings 11/23/20 Early notable gainers among liquid option names on November 23rd
Upgrade	NextCure upgraded to Buy from Hold at Truist » 07:14 03/05/21 03/05 07:14 03/05/21 07:14 NXTC NextCure $11.38 / -0.22 (-1.90%) Truist analyst Asthika… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NXTC NextCure $11.38 / -0.22 (-1.90%) 01/14/21 NextCure appoints Han Myint MD as chief medical officer 12/17/20 NextCure 'working to modify' NC318 clinical program to enable trial enrollment NXTC NextCure $11.38 / -0.22 (-1.90%) 06:52 Today Truist NextCure upgraded to Buy from Hold at Truist 03/04/21 Piper Sandler NextCure price target lowered to $26 from $32 at Piper Sandler 01/15/21 BofA NextCure downgraded to Underperform on low conviction in NC318 at BofA 01/15/21 BofA NextCure downgraded to Underperform from Neutral at BofA NXTC NextCure $11.38 / -0.22 (-1.90%) 03/04/21 NextCure reports FY20 EPS ($1.33), consensus ($1.34) 11/05/20 NextCure reports Q3 EPS (59c), consensus (57c)
Recommendations	T2 Biosystems price target lowered to $1.65 from $2.40 at Alliance Global Partners » 07:13 03/05/21 03/05 07:13 03/05/21 07:13 TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/04/21 T2 Biosystems T2SARS-CoV can detect Brazil P.1 variant SARS-CoV 2 virus 01/11/21 T2 Biosystems: T2SARS-CoV-2 Panel can detect multiple variants of COVID-19 01/07/21 T2 Biosystems appoints Aparna Ahuja as CMO 10/19/20 Sepsis Alliance elects T2 Biosystems CEO as board member TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 01/27/21 Alliance Global Partners T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners 11/05/20 Alliance Global Partners T2 Biosystems price target raised to $2.60 from $1.65 at Alliance Global 10/07/20 BTIG T2 Biosystems initiated with a Buy at BTIG 09/30/20 JonesTrading JonesTrading reiterates $3.50 target on T2 Biosystems after BARDA contract TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems sees FY21 revenue $24M-$26M, consensus $33.27M 03/04/21 T2 Biosystems reports Q4 EPS (7c), consensus (7c) 01/26/21 T2 Biosystems sees FY20 revenue $18.1M, consensus $19.32M 01/26/21 T2 Biosystems sees Q4 revenue $7.8M, consensus $9.01M TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 02/05/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/12/21 Fly Intel: Pre-market Movers TTOO T2 Biosystems $1.95 / -0.0851 (-4.18%) 03/04/21 T2 Biosystems options imply 26.4% move in share price post-earnings 02/10/21 Largest borrow rate increases among liquid names 01/12/21 Unusually active option classes on open January 12th 10/06/20 Largest borrow rate increases among liquid names

Downgrade	Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum » 07:12 03/05/21 03/05 07:12 03/05/21 07:12 SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Smith & Wesson Brands jumps 5% to $16.64 after Q3 results beat estimates 03/04/21 Smith & Wesson Brands reports Q3 gross margin 42.6% vs. 28% last year 03/04/21 Smith & Wesson Brands announces $100M share repurchase plan 03/03/21 FBI reports 3.44M NICS firearm background checks in February SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 B. Riley Securities B. Riley starts American Outdoor Brands with Buy, $32 price target 12/04/20 Lake Street Lake Street ups Smith & Wesson Brands price target to $28 after earnings 10/05/20 B. Riley Securities Firearm demand has seen meaningful uptick, says B. Riley Securities 09/24/20 Fly Intel: Top five analyst initiations SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Smith & Wesson Brands reports Q3 EPS $1.12, consensus 76c 12/03/20 Smith & Wesson Brands reports Q2 adjusted EPS 93c, consensus 63c SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 12/15/20 Smith & Wesson sues New Jersey to block subpoena related to marketing, WSJ says SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 03/04/21 Fly Intel: After-Hours Movers 12/16/20 Fly Intel: After-Hours Movers 12/03/20 Fly Intel: After-Hours Movers SWBI Smith & Wesson Brands $15.79 / -0.54 (-3.31%) 02/18/21 Smith and Wesson call volume above normal and directionally bullish 02/03/21 Smith and Wesson put volume heavy and directionally bearish 01/27/21 Smith and Wesson put volume heavy and directionally bearish 01/11/21 Smith and Wesson call volume above normal and directionally bullish
Earnings	LifeMD sees Q1 revenue exceeding $17M, up over 295% vs. last year » 07:12 03/05/21 03/05 07:12 03/05/21 07:12 LFMD LifeMD $14.36 / -1.91 (-11.74%) LifeMD expects revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options LFMD LifeMD $14.36 / -1.91 (-11.74%) 02/22/21 Conversion Labs to begin trading as LifeMD LFMD LifeMD $14.36 / -1.91 (-11.74%) 02/22/21 One new option listing and ten option delistings on February 22nd
Recommendations	Dyne Therapeutics weakness a buying opportunity, says Stifel » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) Stifel analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 03/04/21 Dyne Therapeutics expects cash to fund requirements into 2H24 03/04/21 Dyne Therapeutics appoints Wildon Farwell as CMO 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 02/09/21 Dyne Therapeutics initiated with a Buy at JonesTrading 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 03/04/21 Dyne Therapeutics reports Q4 EPS (64c), consensus (37c) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) 21 Jan 17 Sep DYN Dyne Therapeutics $15.77 / -0.97 (-5.79%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever
Initiation	Saratoga Investment initiated with an Outperform at Hovde Group » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 SAR Saratoga Investment $22.85 / -0.24 (-1.04%) Hovde Group analyst Bryce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/06/21 Saratoga Investment increases quarterly cash dividend to 42c per share 10/07/20 Saratoga Investment increases quarterly dividend by 1c to 41c per share SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/07/21 Ladenburg Saratoga Investment price target raised to $25 from $21 at Ladenburg 01/07/21 Janney Montgomery Scott Saratoga Investment upgraded to Buy from Neutral at Janney Montgomery Scott 07/13/20 Compass Point Saratoga Investment price target raised to $19.75 from $16.50 at Compass Point SAR Saratoga Investment $22.85 / -0.24 (-1.04%) 01/06/21 Saratoga Investment reports Q3 adjusted EPS 50c, consensus 47c 10/07/20 Saratoga Investment reports Q2 adj. EPS 49c, consensus 26c
Initiation	Oaktree Specialty Lending initiated with an Outperform at Hovde Group » 07:11 03/05/21 03/05 07:11 03/05/21 07:11 OCSL Oaktree Specialty Lending / + Hovde Group analyst Bryce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OCSL Oaktree Specialty Lending / + 11/19/20 Oaktree Specialty Lending raises quarterly cash distribution to 11c per share 10/29/20 Oaktree Specialty Lending, Oaktree Strategic Income enter merger agreement OCSL Oaktree Specialty Lending / + 06/19/20 Janney Montgomery Scott Oaktree Specialty Lending upgraded to Buy at Janney Montgomery Scott 06/19/20 Janney Montgomery Scott Oaktree Specialty Lending upgraded to Buy from Neutral at Janney Montgomery Scott 03/05/20 National Securities Oaktree Specialty Lending initiated with a Buy at National Securities OCSL Oaktree Specialty Lending / + 11/19/20 Oaktree Specialty Lending reports Q4 adjusted NII 17c, consensus 12c 03/15/21 Oaktree Specialty Lending Corp

Events

Earnings calls, analyst events, roadshows and more

GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: February 2021 Government Event
Today at 08:30

Employment Situation: Average Workweek: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Qiagen announces shipments of test kits for coronavirus SARS-CoV-2

TODAY'S FREE FLY STORIES

Get Full Fly Access